Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stenoparib in metastatic breast cancer selected by DRP
NCT03562832Phase 2Completed
- Sponsor
- Allarity Therapeutics
- Start
- Jun 2018
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of stenoparib in breast cancer, sponsored by Allarity Therapeutics. Started Jun 2018; status: completed.
02
Drugs
stenoparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03562832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03562832.